Improving Addiction Care Team (IMPACT): OHSU Pharmacy and Therapeutics Policy on use of Medication to Treat Opioid Use Disorder (Pregnant and Non-Pregnant Patients)

This resource is Oregon Health & Science University’s pharmacy and therapeutics policy on the use of medications (methadone, buprenorphine, and naltrexone) for opioid withdrawal management or opioid maintenance therapy in patients with opioid use disorder who are hospitalized or seen in the emergency department. Continue reading

Improving Addiction Care Team (IMPACT): Withdrawal Management

This resource serves as a guide to managing opioid or alcohol withdrawal in hospitalized patients with substance use disorder. It is one of the protocols and tools developed for Oregon Health & Science University’s Improving Addiction Care Team (IMPACT) program, which provides addiction medicine consultations to patients treated in the hospital who have a diagnosis of substance use disorder. Continue reading

Improving Addiction Care Team (IMPACT): Medications to Treat Substance use Disorders

This resource serves as a guide to beginning medication assisted treatment for individuals with opioid use disorder or alcohol use disorder in the hospital setting. It is one of the protocols and tools developed for Oregon Health & Science University’s Improving Addiction Care Team (IMPACT) program, which provides addiction medicine consultations to patients treated in the hospital who have a diagnosis of substance use disorder. Continue reading

Efficacy for Use of Detoxification Alone as a Treatment for Opioid Use Disorder

State officials participating in the Medicaid Evidence-based Decisions Project requested this rapid evidence review on the role of inpatient or residential detoxification for the treatment of opioid use disorder (OUD). As this 2-page document states, research is clear and addiction experts agree that detoxification alone is not a stand-alone treatment for OUD, but is merely the first step in a providing an individualized treatment plan which may include medication assisted treatment. Continue reading

MOMS Care Coordination Model

Policymakers and clinicians in Ohio developed the Maternal Opiate Medical Support (MOMS) model of providing prenatal, obstetrical, and postpartum care for pregnant women with opioid use disorder. This guide includes a process to assess readiness to adopt the MOMS model and an Continue reading

Healthy Outcomes for Mom and Baby: Neonatal Opioid Withdrawal/Neonatal Abstinence Syndrome

This 2 page clinician guide provides an overview of how to assess and manage women with opioid use during pregnancy and how to provide optimal care to infants with neonatal opiate withdrawal/neonatal abstinence syndrome. Prepared by the Arizona Department of Health Services and the Arizona Statewide Task Force on Preventing Prenatal Exposure to Alcohol and Other Drugs.

Funding Source:  Arizona Department of Health Services, Arizona Statewide Task Force on Preventing Prenatal Exposure to Alcohol and Other Drugs

Journeys of Hope: Mommies and Babies Overcoming Neonatal Withdrawal Syndrome/Neonatal Abstinence Syndrome

A 15-minute video of women talking about their experiences of getting help to address their opioid addiction and confront stigma during their pregnancies. Includes information about the importance of seeking treatment and support during pregnancy and in the postpartum period, and how these women worked with their providers to ensure a successful outcome for themselves and their Continue reading

Support for Hospital Opioid Use Treatment (SHOUT)

This website includes links to 7 webinars that make up the Support for Hospital Opioid Use Treatment (Project SHOUT) initiative of the California Health Care Foundation. Topics covered in the webinar series include: the case for inpatient opioid agonist therapy; buprenorphine and methadone induction; acute pain and Continue reading